[ad_1]
Health Minister Aistė Šuksta told BNS on Friday evening that if it became clear that COVID-19 vaccine manufacturers BioNTech and Pfizer had reduced the planned quantities of the vaccine to be delivered in the near future, the vaccine would be used only for the booster shot for the second week of February.
Meanwhile, the Moderna vaccine will be used for further vaccination of priority groups.
On December 27, CONID-19, developed by BioNTech and Pfizer at five central treatment facilities in the country, will be the first to be vaccinated.
This vaccine is administered twice with an interval of three weeks after the first vaccination and adequate protection of the immune system is achieved one week after the second vaccination.
The first physicians to work with COVID-19 patients.
The Vilnius Santara BNS Clinic reported that on Sunday it will vaccinate the doctors who were vaccinated on December 27. Then it was announced that there were 745 of them.
At the Kaunas clinics, the booster vaccination will also start on Sunday and continue on the other days for those employees who have already passed three weeks after the first vaccination.
Hospitals that have received COVID-19 during that time will not be vaccinated by hospitals for now; they will be vaccinated later. There were seven such cases in the Kaunas clinics and 79 in the Santara clinics.
Workers may have been infected with coronavirus both before and after vaccination because a single dose of the vaccine still does not develop immunity against the disease.
As announced by the Health Ministry on Friday, Pfizer announced that 54,405 doses of the vaccine will be delivered instead of the planned 108,810 doses over the next four weeks.
Based on available data, Pfizer has temporarily reduced the supply of COVID-19 while reviewing its technology processes.
According to the ministry, a representative from BioNTech and Pfizer assures that the number of doses of vaccines that will be delivered later will increase. The manufacturer is committed to providing information on the exact number of vaccines that will be administered in the near future.
Vaccination priorities will not change and vaccination will continue as planned, only longer than planned.
According to the ministry, the expected delivery volumes are reduced for all countries of the European Union.
The total quantity of BioNTech and Pfizer vaccines ordered by Lithuania is 3.1 million. and will not change as a result of this temporary reduction in supply.
[ad_2]
